CanBas Co., Ltd.
Status: Publicly traded
Direct answer
CanBas Co., Ltd. is publicly traded on JPX under the ticker 4575.T.
CanBas Co., Ltd. is a biopharmaceutical company in the clinical stage, dedicated to discovering and developing new therapies for cancer patients. Its main investigational compounds include CBP501, a calmodulin-modulating peptide aimed at treating various cancers, and CBS9106, a reversible exportin-1 inhibitor currently in Phase I clinical trials for solid tumors. The company also engages in a strategic partnership...
Can you invest in CanBas Co., Ltd.?
Yes. CanBas Co., Ltd. trades publicly on JPX as 4575.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CanBas Co., Ltd.
Detailed equity research is provided by MarketSnap.